Alomfilimab (KY-1044) is a humanized monoclonal antibody targeting the inducible co-stimulator receptor (ICOS). As a selective ICOS blockade, it manipulates ICOS expression heterogeneity on T-cell subtypes. It can be used to study tumors.
Purity:
99.51%
CAS Number:
[2489390-15-8]
Target:
Others|||Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted
